No profile data available.
Natural Alternatives International, Inc. (NAII) is a healthcare company in the additional production service providers industry, based in Carlsbad, United States, with about 301 full-time employees.
It reported revenue of $129.86 million for fiscal year 2025, up 14.1% from fiscal year 2024, and net income of -$13.58 million. In Q1 2026 (the quarter ended September 30, 2025) revenue was $37.73 million, up 13.8% from a year before. Its largest business segment, Private-Label Contract Manufacturing, brought in 94% of segment revenue in fiscal year 2025; United States was the largest region with 61%. Its market capitalization was $7.14 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2025; market data as of October 9, 2026.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing.
Natural Alternatives International reported $129.86 million in revenue for fiscal year 2025, up 14.1% from $113.80 million in fiscal year 2024. In Q1 2026 revenue was $37.73 million.
Private-Label Contract Manufacturing, with $121.78 million or 94% of segment revenue in fiscal year 2025. Next: Patent and Trademark Licensing (6%).
United States: 61% of revenue by region in fiscal year 2025, followed by Markets outside of The United States (39%).
$7.14 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional production service providers) include Maravai LifeSciences Holdings, Inc. (MRVI), DSwiss, Inc. (DQWS), Bio Essence Corporation (BIOE), Integrated BioPharma, Inc. (INBP).